Yishen Tongluo formula alleviates diabetic kidney disease through regulating Sirt6/TGF-β1/Smad2/3 pathway and promoting degradation of TGF-β1
Xiaowei Zhang, Liang Zhao, Shixie Xiang, Yiran Sun, Pan Wang, Jenny Jie Chen, Brian Sheng-Xian Teo, Zhishen Xie, Zhenqiang Zhang, Jiangyan Xu
Topics & Concepts
Transforming growth factorKidney diseaseKidneyMedicineDegradation (telecommunications)EndocrinologyInternal medicinePharmacologyEngineeringTelecommunicationsChronic Kidney Disease and DiabetesTGF-β signaling in diseasesNF-κB Signaling Pathways